Albumin Substitution in Decompensated Liver Cirrhosis: Don’t Forget Zinc
Decompensated liver cirrhosis has a dismal prognosis, with patients surviving on average for 2–4 years after the first diagnosis of ascites. Albumin is an important tool in the therapy of cirrhotic ascites. By virtue of its oncotic properties, it reduces the risk of cardiovascular dysfunction after...
Guardado en:
Autores principales: | Kurt Grüngreiff, Thomas Gottstein, Dirk Reinhold, Claudia A. Blindauer |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a20f9cfe3ead4174bc1a66af0e573311 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Albumin Administration is Efficacious in the Management of Patients with Cirrhosis: A Systematic Review of the Literature
por: Zaccherini G, et al.
Publicado: (2020) -
Prevalence of Zinc Deficiency in Healthy 1–3-Year-Old Children from Three Western European Countries
por: Mirjam Vreugdenhil, et al.
Publicado: (2021) -
Correlation between Serum Zinc Levels and Levodopa in Parkinson’s Disease
por: Hirofumi Matsuyama, et al.
Publicado: (2021) -
The Effects of Probiotic and Zinc on Hemoglobin Levels in Malnourished Rats
por: Perez Wahyu Purnasari, et al.
Publicado: (2021) -
Clinical and laboratory characteristics of cirrhotic patients associated with moderate and severe malnutrition
por: Barcelos,Samantha Thifani Alrutz, et al.
Publicado: (2014)